Cited by 34Adrenal and Paraganglionic TumorsAdrenal Hormones and DisordersHormonal Regulation and Hypertension

Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas.

Sakai, Y, Yanase, T, Hara, T, Takayanagi, R, Haji, M, Nawata, H·1994·The Journal of Clinical Endocrinology & Metabolism

Abstract

The production of adrenal androgens can be modulated by the activities of steroidogenic enzymes and by the electron transfer system, NADPH-cytochrome P450 reductase (Red) and cytochrome b5 (b5), both of which have been shown to increase 17,20-lyase activity in vitro. To clarify the mechanism of diminished secretion of adrenal androgens in patients with adrenocortical adenoma and Cushing's syndrome and of excess secretion in patients with adrenocortical carcinoma, we investigated the enzymatic activities of cytochrome P45017 alpha, 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), and Red as well as the content of b5 in five adenomas, three carcinomas, and two normal adrenal glands. An in vitro enzyme assay using a microsomal fraction of the tissues indicated that all the tumors had almost the same degree of 17 alpha-hydroxylase activities as the normal adrenals. However, the relative activity ratio of 17,20-lyase to 17 alpha-hydroxylase of the three adenomas was markedly diminished, and 3 beta-HSD activity was apparently lower in the three carcinomas. The messenger RNA concentrations of P45017 alpha were similar in all tumors, whereas those of 3 beta-HSD were markedly lower in the carcinomas than in other tissues. Both the content of b5 and the activity of Red were significantly lower in the adenomas. These results suggest that low concentrations of adrenal androgens in patients with adrenocortical adenomas are mainly due to low 17,20-lyase activity, which may be explained in part by a lower content of b5 and Red. In addition, high concentrations of adrenal androgens in patients with adrenocortical carcinoma are mainly due to the diminished activity of 3 beta-HSD.

Integrity signals

Registry

Crossref · 10.1210/jcem.78.1.8288710

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies of DNA from affected patients revealed that CYP11A1 gene encoding P450scc was normal, and in 1995 disease was termed 'congenital lipoid adrenal hyperplasia (lipoid CAH)', caused by mutations in StAR.

    “However, studies of DNA from affected patients revealed that the CYP11A1 gene encoding P450scc was normal21,22,23,24), and in 1995 this disease was more properly termed 'congenital lipoid adrenal hyperplasia (lipoid CAH)', and it was caused by mutations in the gene encoding StAR3,25).”

    From Congenital lipoid adrenal hyperplasia (2014) · cites this paper as [23]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sakai, Y., Yanase, T., Hara, T., Takayanagi, R., Haji, M., & Nawata, H.
Affiliations
Kyushu University (JP)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1994-01
Volume
78
Issue
1
Pages
36-40
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1980462887
Cited by
34
References
18
Citations by year
2025: 2 · 2021: 1 · 2019: 3 · 2018: 2 · 2015: 2 · 2014: 1
FWCI
1.27
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
adrenal androgens, adrenal adenoma, adrenocortical carcinoma, Cushing's syndrome, 17,20-lyase, 17α-hydroxylase, 3β-hydroxysteroid dehydrogenase, NADPH-cytochrome P450 reductase, cytochrome b5, steroidogenic enzymes, enzyme activity, messenger RNA expression, adrenal microsomes
MeSH terms
Adenoma, Adrenal Cortex Neoplasms, Adrenal Glands, Adult, Androgens, Carcinoma, Child, Child, Preschool, Female, Humans, Infant, Microsomes, Middle Aged, NADPH-Ferrihemoprotein Reductase, RNA, Messenger, Steroid 17-alpha-Hydroxylase, 3-Hydroxysteroid Dehydrogenases, Cytochromes b5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review